Interleukin-5 Antagonist Monoclonal Antibody Therapy Improves Symptoms and Reduces Steroid Dependence in Eosinophilic Myocarditis Patients

Eosinophilic myocarditis (EM) is a rare disease associated with significant morbidity and mortality. This case series follows the clinical courses of 3 patients with EM. The use of mepolizumab, an anti-interleukin-5 monoclonal antibody, as an adjunctive treatment was associated with stabilization of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JACC. Case reports 2024, Vol.29 (7), p.102267-102267
Hauptverfasser:	Trovato, Vincenzo, Asada, Ashlee, Fussner, Lynn, Curtis, Casey, Kahwash, Rami
Format:	Report
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!